Terns Pharmaceuticals (TERN) News Today → Fidelity, Bezos, Goldman Bet Big on Tiny Biotech (From Behind the Markets) (Ad) Free TERN Stock Alerts $6.05 +0.29 (+5.03%) (As of 05/8/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineTerns Pharmaceuticals Announces Leadership Changesglobenewswire.com - May 8 at 4:05 PMTerns Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference 2024globenewswire.com - May 7 at 4:05 PMTerns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)globenewswire.com - May 3 at 4:05 PMTerns Pharmaceuticals (NASDAQ:TERN) Given "Market Outperform" Rating at JMP Securitiesamericanbankingnews.com - May 1 at 5:00 AMTerns Pharmaceuticals (NASDAQ:TERN) Receives "Neutral" Rating from HC Wainwrightamericanbankingnews.com - May 1 at 5:00 AMTerns Pharmaceuticals' (TERN) Neutral Rating Reiterated at HC Wainwrightmarketbeat.com - April 30 at 1:31 PMBuy Rating Reiterated for ARQT Amidst Strong Zoryve Performance and Market Resiliencemarkets.businessinsider.com - April 30 at 9:20 AMTerns Pharmaceuticals Announces Data from Ongoing Phase 1 Pharmacokinetic Study of Allosteric BCR-ABL Inhibitor TERN-701 in Adult Healthy Volunteers and Highlights Potential for Competitive Differentiationglobenewswire.com - April 29 at 4:05 PMOptimistic Buy Rating for Terns Pharmaceuticals Based on TERN-701 Market Potential and Strategymarkets.businessinsider.com - April 26 at 4:36 PMAnalysts Offer Insights on Healthcare Companies: AstraZeneca (AZN) and BioMarin Pharmaceutical (BMRN)markets.businessinsider.com - April 26 at 11:36 AMTerns Pharmaceuticals Inc Ordinary Sharesmorningstar.com - April 18 at 6:23 PMTerns Pharmaceuticals, Inc.: Terns Pharmaceuticals Appoints Melita Sun Jung as Chief Business Officerfinanznachrichten.de - April 11 at 8:35 AMTerns Pharmaceuticals Appoints Melita Sun Jung as Chief Business Officerglobenewswire.com - April 10 at 4:05 PMMadrigal announces US launch of NASH/MASH drug Rezdifframsn.com - April 9 at 10:28 AMVivo Capital entities sell Terns Pharmaceuticals shares worth $2.8 millioninvesting.com - April 5 at 10:17 AMVivo Opportunity, Llc Sells 138,066 Shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Stockinsidertrades.com - April 5 at 5:24 AMTerns Pharmaceuticals, Inc. (NASDAQ:TERN) Major Shareholder Vivo Opportunity, Llc Sells 181,117 Sharesinsidertrades.com - April 4 at 6:15 AMThis small-cap stock is expected to take off - if its weight-loss pill trial succeedsmorningstar.com - March 30 at 7:03 PMThis small-cap stock is expected to take off — if its weight-loss pill trial succeedsmarketwatch.com - March 28 at 3:24 PMUBS Group Lowers Terns Pharmaceuticals (NASDAQ:TERN) Price Target to $18.00marketbeat.com - March 27 at 3:09 PMHere’s Why Ozempic And Mounjaro Rivals Won’t Topple Weight Loss Drugmakers Novo Nordisk And Eli Lilly Anytime Soonmsn.com - March 27 at 9:31 AMWall Street's Favorite Biotech Stocks? 3 Names That Could Make You Filthy Richinvestorplace.com - March 25 at 3:00 PMOptimistic Buy Rating for Terns Pharmaceuticals Based on Strong Clinical Pipeline and Financial Stabilitymarkets.businessinsider.com - March 21 at 6:49 AMHC Wainwright Reaffirms "Neutral" Rating for Terns Pharmaceuticals (NASDAQ:TERN)marketbeat.com - March 18 at 6:33 PMTerns Pharmaceuticals (NASDAQ:TERN) PT Raised to $19.00marketbeat.com - March 18 at 6:33 PMTerns Pharmaceuticals (NASDAQ:TERN) PT Lowered to $15.00marketbeat.com - March 18 at 5:31 PMTERN Apr 2024 15.000 callfinance.yahoo.com - March 16 at 1:45 PMTerns Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updatesglobenewswire.com - March 14 at 4:05 PMTerns Pharmaceuticals, Inc.: Terns Pharmaceuticals Announces Orphan Drug Designation Granted to TERN-701 for the Treatment of Chronic Myeloid Leukemiafinanznachrichten.de - March 12 at 4:18 AMTerns Pharmaceuticals Announces Orphan Drug Designation Granted to TERN-701 for the Treatment of Chronic Myeloid Leukemiaglobenewswire.com - March 11 at 4:05 PMTerns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)globenewswire.com - March 7 at 4:05 PMFmr LLC Sells 1,932,296 Shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN)marketbeat.com - March 4 at 5:19 AMAcuta Capital Partners LLC Lowers Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN)marketbeat.com - March 3 at 12:18 PMTerns Pharmaceuticals, Inc. (NASDAQ:TERN) Holdings Lifted by Braidwell LPmarketbeat.com - March 1 at 10:18 AMBarclays PLC Decreases Stake in Terns Pharmaceuticals, Inc. (NASDAQ:TERN)marketbeat.com - February 29 at 4:16 AMTerns Pharmaceuticals to Participate in Upcoming March Investor Conferencesglobenewswire.com - February 27 at 4:05 PMSilverarc Capital Management LLC Trims Stock Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN)marketbeat.com - February 18 at 12:54 PMTerns Pharmaceuticals (NASDAQ:TERN) Trading Up 10%marketbeat.com - February 16 at 2:56 PMTerns Pharmaceuticals, Inc. (NASDAQ:TERN) Receives Consensus Rating of "Moderate Buy" from Brokeragesmarketbeat.com - February 10 at 1:29 AMTerns Pharmaceuticals, Inc.: Terns Pharmaceuticals Reports Inducement Grants to New Chief Executive Officer Under Nasdaq Listing Rule 5635(C)(4)finanznachrichten.de - February 9 at 9:57 AMTerns Pharmaceuticals, Inc.: Terns Pharmaceuticals Appoints Amy Burroughs as Chief Executive Officerfinanznachrichten.de - February 7 at 5:40 PMTerns Pharmaceuticals Reports Inducement Grants to New Chief Executive Officer Under Nasdaq Listing Rule 5635(C)(4)finance.yahoo.com - February 7 at 5:40 PMTerns Pharma Names Amy Burroughs as CEOmarketwatch.com - February 7 at 12:40 PMTerns Pharmaceuticals Appoints Amy Burroughs As CEOmarkets.businessinsider.com - February 7 at 12:40 PMBuy Rating on Terns Pharmaceuticals: Anticipated Clinical Milestones and Therapeutic Developments Signal Growthmarkets.businessinsider.com - January 13 at 1:36 AMHC Wainwright Weighs in on Terns Pharmaceuticals, Inc.'s FY2028 Earnings (NASDAQ:TERN)marketbeat.com - January 11 at 8:27 AMTerns Pharmaceuticals (NASDAQ:TERN) PT Lowered to $5.50 at HC Wainwrightmarketbeat.com - January 10 at 8:22 AMTerns Pharmaceuticals, Inc. (NASDAQ:TERN) Receives Consensus Recommendation of "Moderate Buy" from Analystsmarketbeat.com - December 22 at 2:20 AMAnalysts Are Bullish on These Healthcare Stocks: Terns Pharmaceuticals (TERN), Cooper Co (COO)markets.businessinsider.com - December 11 at 5:50 PMTerns Pharmaceuticals to Present at the JMP Securities Hematology and Oncology Summitfinance.yahoo.com - November 29 at 5:42 PM Get Terns Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TERN and its competitors with MarketBeat's FREE daily newsletter. Email Address BREAKING – Pentagon to Spend $20 Billion on “Distributed AI” (Ad)BREAKING - Pentagon to Spend $20 Billion on "Distributed AI" The U.S. Space Force calls it a "game changer." And one tiny firm is poised to win the contract to build it. Discover the name and ticker of this $2 stock here >>> TERN Media Mentions By Week TERN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TERN News Sentiment▼0.000.36▲Average Medical News Sentiment TERN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TERN Articles This Week▼22▲TERN Articles Average Week Get Terns Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TERN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Rani Therapeutics News Today Mereo BioPharma Group News Today Erasca News Today Nature's Sunshine Products News Today Harrow News Today ADC Therapeutics News Today Amarin News Today Precigen News Today Atai Life Sciences News Today Alto Neuroscience News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TERN) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressCharles Payne Demystifies OptionsUnstoppable ProsperityWatch this FREE trading tutorial while it’s still availableInvestorPlaceShocking: One AI startup's revenue could surge 4,735%Manward Press[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Terns Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
